Current Report Filing (8-k)
15 February 2023 - 01:02AM
Edgar (US Regulatory)
0001138723false00011387232023-02-142023-02-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
Date of Report (Date of earliest event reported):
February 14, 2023
|
ACCURAY INCORPORATED
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
Delaware
|
001-33301
|
20-8370041
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
1310 Chesapeake Terrace
|
|
|
Sunnyvale,
California
|
|
94089
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
Registrant’s Telephone Number, Including Area Code:
408
716-4600
|
(Former Name or Former Address, if Changed Since Last
Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value per share
|
|
ARAY
|
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
☐
Item 7.01 Regulation FD Disclosure.
On February 14, 2023, Accuray Incorporated (the “Company”) intends
to present the management presentation slides attached hereto as
Exhibit 99.1 during the virtual BTIG MedTech, Digital Health, Life
Science & Diagnostic Tools Conference to discuss, among other
things, the long-term business and growth strategies for the
Company. Such slides may be used in additional presentations to
investors and analysts from time to time. The management
presentation slides will also be posted on the investor relations
portion of the Company’s website.
The information contained in this Current Report on Form 8-K,
including Exhibit 99.1, is furnished pursuant to Item 7.01 and
shall not be deemed to be “filed” for the purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that Section, nor
shall it be incorporated by reference into a filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as
shall be expressly set forth by specific reference in such a
filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
ACCURAY INCORPORATED
|
|
|
|
|
|
|
Date:
|
February 14, 2023
|
By:
|
/s/ Jesse Chew
|
|
|
|
|
Jesse Chew
Senior
Vice President & General Counsel
|
3
Accuray (NASDAQ:ARAY)
Historical Stock Chart
From May 2023 to Jun 2023
Accuray (NASDAQ:ARAY)
Historical Stock Chart
From Jun 2022 to Jun 2023
